MT
Mycrodose Therapeutics develops advanced drug delivery systems that enhance the precision and efficacy of pharmaceutical treatments. The company addresses the challenge of inefficient drug administration by improving bioavailability and patient compliance through targeted delivery mechanisms.
Updated 20 months ago
Funding
Funding not disclosed
KATCFunding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Mycrodose Therapeutics develops advanced drug delivery systems that enhance the precision and efficacy of pharmaceutical treatments. The company addresses the challenge of inefficient drug administration by improving bioavailability and patient compliance through targeted delivery mechanisms.